ViewRay, Inc. (OTC: VRAY) is a Cleveland, Ohio-based medical device company that develops advanced radiation therapy technology for the treatment of cancer. The MRIdian® system provides continuous soft-tissue imaging during treatment, using MRI-guided radiation therapy, so that clinicians are able to see where the actual radiation dose is being delivered and adapt to changes in the patient’s anatomy. ViewRay and MRIdian are registered trademarks of ViewRay, Inc. For more information, visit the company’s website at www.viewray.com